Redox- and PH-Responsive Polymersomes with Ferrocene Moieties Exhibiting Peroxidase-like, Chemoenzymatic Activity and HO-Responsive Release Behavior
Overview
Biology
Molecular Biology
Authors
Affiliations
The development of compartments for the design of cascade reactions in a local space requires a selective spatiotemporal control. The combination of enzyme-loaded polymersomes with enzymelike units shows a great potential in further refining the diffusion barrier and the type of reactions in nanoreactors. Herein, pH-responsive and ferrocene-containing block copolymers were synthesized to realize pH-stable and multiresponsive polymersomes. Permeable membrane, peroxidase-like behavior induced by the redox-responsive ferrocene moieties and release properties were validated using cyclovoltammetry, dye TMB assay, and rupture of host-guest interactions with β-cyclodextrin, respectively. Due to the incorporation of different block copolymers, the membrane permeability of glucose oxidase-loaded polymersomes was changed by increasing extracellular glucose concentration and in TMB assay, allowing for the chemoenzymatic cascade reaction. This study presents a potent synthetic, multiresponsive nanoreactor platform with tunable (e.g., redox-responsive) membrane properties for potential application in therapeutics.
Jager E, cernoch P, Vragovic M, Calumby Albuquerque L, Sincari V, Heizer T Biomacromolecules. 2024; 25(7):4192-4202.
PMID: 38917475 PMC: 11238342. DOI: 10.1021/acs.biomac.4c00282.
Liu T, Zhu L, Li C, Yu Y, Zhang Z, Liu H ACS Omega. 2024; 9(22):23772-23781.
PMID: 38854516 PMC: 11154932. DOI: 10.1021/acsomega.4c01715.
Polymersomes as Innovative, Stimuli-Responsive Platforms for Cancer Therapy.
Negut I, Bita B Pharmaceutics. 2024; 16(4).
PMID: 38675124 PMC: 11053450. DOI: 10.3390/pharmaceutics16040463.
Efficacy tumor therapeutic applications of stimuli-responsive block copolymer-based nano-assemblies.
Zhou J, Yang R, Chen Y, Chen D Heliyon. 2024; 10(7):e28166.
PMID: 38571609 PMC: 10987934. DOI: 10.1016/j.heliyon.2024.e28166.
Ornelas C, Astruc D Pharmaceutics. 2023; 15(8).
PMID: 37631259 PMC: 10458437. DOI: 10.3390/pharmaceutics15082044.